Endo International PLC - ENDP (NASDAQ-GS)

5.51
0.12 (-2.13%)
Quotes delayed 15 mins. Currently April 22, 2018 9:40:24 PM
By signing up, you can buy this stock for just $4.95 or purchase it within a Motif
Endo develops and markets prescription drugs primarily for pain management, urology, endocrinology and oncology

Key Financials

Day Range:5.50 - 5.69
52 Week Range:5.27 - 14.15
Open:5.62
Shares:223.34M
Market Cap:1.23B
EPS:-0.41
P/E Ratio:--
Div Yield:--
Performance
Previous close
No Chart Available
Purchase ENDP in a Motif
A motif is an intelligently weighted basket of up to 30 stocks and ETFs built around themes and investing styles.
On our platform, you can buy shares of ENDP not only as a single stock, but also as part of a motif.
Professional Motifs with ENDP
Drug-Patent Cliffs
Drug-Patent Cliffs 13.6% 1 YR RTN The patent clock is ticking down for many big-name drugs. And that has generic drug companies feeling pretty healthy.
View all professional motifs with ENDP
Community Motifs with ENDP
Pharma Rebounce Bet
Pharma Rebounce Bet 6.8% 1 YR RTN
SP Dogs II
SP Dogs II 28.3% 1 YR RTN
View all community motifs with ENDP
What Others Think About ENDP
Profectus Systems
Mid cap trading model subcriptions available at Profectus Systems $NVAX $AMD $CHK $WLL $ECA $RIG $ENDP $GPRO $AUY $X $FTR $COTY $KGC $SWN
1
Jonny_Red�� [nFÜSZ]
@EnterpriseLeade Would have posted higher earnings if generics business leadership new how to manage. $ENDP has co… twitter.com/i/web/status/9…
Dispatch Tribunal
Endo International plc $ENDP Expected to Post Quarterly Sales of $687.12 Million dispatchtribunal.com/?p=1795895
The Markets Daily
Analysts Expect Endo International plc $ENDP Will Post Earnings of $0.54 Per Share zpr.io/nwYTR
Enterprise Leader
Zacks: Analysts Anticipate Endo International plc $ENDP Will Announce Quarterly Sales of $687.12 Million theenterpriseleader.com/?p=586929
Registrar Journal
Analysts Expect Endo International plc $ENDP Will Post Earnings of $0.54 Per Share registrarjournal.com/?p=607043
ChartMill
$ENDP : The EPS is expected to grow by 73.89% on average over the next 2 years. This is a very strong growth.… twitter.com/i/web/status/9…
Related Companies Within The Drug Manufacturers - Other Sector
NVO
RDUS